1. Nickel JC, Nyberg LM, Hennenfent M. Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network. Urology. 1999; 54:229–33.
Article
2. Nickel JC, Downey J, Hunter D, Clark J. Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol. 2001; 165:842–5.
Article
3. Bahk JY, Hyun JS, Lee JY, Kim J, Cho YH, Lee JH, et al. Concentration of ofloxacin in canine prostate tissue and prostate fluid after intraprostatic injection of biodegradable sustained-releasing microspheres containing ofloxacin. J Urol. 2000; 163:1560–4.
Article
4. Faulkner DJ. Marine natural products. Nat Prod Rep. 2002; 19:1–48.
Article
5. Wijesinghe WA, Jeon YJ. Exploiting biological activities of brown seaweed Ecklonia cava for potential industrial applications: a review. Int J Food Sci Nutr. 2012; 63:225–35.
6. Robinette CL. Sex-hormone-induced inflammation and fibromuscular proliferation in the rat lateral prostate. Prostate. 1988; 12:271–86.
Article
7. Naslund MJ, Strandberg JD, Coffey DS. The role of androgens and estrogens in the pathogenesis of experimental nonbacterial prostatitis. J Urol. 1988; 140:1049–53.
Article
8. Kim DS, Lee EJ, Cho KS, Yoon SJ, Lee YH, Hong SJ. Preventive effects of oligomerized polyphenol on estradiol-induced prostatitis in rats. Yonsei Med J. 2009; 50:391–8.
Article
9. Seo SI, Lee SJ, Kim JC, Choi YJ, SW SW, Hwang TK, et al. Effects of androgen deprivation on chronic bacterial prostatitis in a rat model. Int J Urol. 2003; 10:485–91.
Article
10. Gerard-Monnier D, Erdelmeier I, Regnard K, Moze-Henry N, Yadan JC, Chaudiere J. Reactions of 1-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Analytical applications to a colorimetric assay of lipid peroxidation. Chem Res Toxicol. 1998; 11:1176–83.
11. Kang HS, Chung HY, Jung JH, Son BW, Choi JS. A new phlorotannin from the brown alga Ecklonia stolonifera. Chem Pharm Bull (Tokyo). 2003; 51:1012–4.
Article
12. Kang KA, Lee KH, Chae S, Koh YS, Yoo BS, Kim JH, et al. Triphlorethol-A from Ecklonia cava protects V79-4 lung fibroblast against hydrogen peroxide induced cell damage. Free Radic Res. 2005; 39:883–92.
13. Wijesekara I, Yoon NY, Kim SK. Phlorotannins from Ecklonia cava (Phaeophyceae): biological activities and potential health benefits. Biofactors. 2010; 36:408–14.
Article
14. Shull JD, Gorski J. Regulation of prolactin gene transcription in vivo: interactions between estrogen, pimozide, and alpha-er-gocryptine. Mol Pharmacol. 1990; 37:215–21.
15. Tangbanluekal L, Robinette CL. Prolactin mediates estradiol-induced inflammation in the lateral prostate of Wistar rats. Endocrinology. 1993; 132:2407–16.
Article
16. Wilson MJ, Woodson M, Wiehr C, Reddy A, Sinha AA. Matrix metalloproteinases in the pathogenesis of estradiol-induced nonbacterial prostatitis in the lateral prostate lobe of the Wistar rat. Exp Mol Pathol. 2004; 77:7–17.
Article
17. Arakawa S, Matsui T, Gohji K, Okada H, Kamidono S. Prostatitis–the Japanese viewpoint. Int J Antimicrob Agents. 1999; 11:201–3.
Article
18. Maher J, Yamamoto M. The rise of antioxidant signaling–the evolution and hormetic actions of Nrf2. Toxicol Appl Pharmacol. 2010; 244:4–15.
Article
19. Heo SJ, Park PJ, Park EJ, Kim SK, Jeon YJ. Antioxidant activity of enzymatic extracts from a brown seaweed Ecklonia cava by electron spin resonance spectrometry and comet assay. Eur Food Res Technol. 2005; 221:41–7.
Article
20. Yasmeen T, Qureshi GS, Perveen S. Adverse effects of diclofenac sodium on renal parenchyma of adult albino rats. J Pak Med Assoc. 2007; 57:349–51.
21. Van Hecken A, Schwartz JI, Depre M, De Lepeleire I, Dallob A, Tanaka W, et al. Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers. J Clin Pharmacol. 2000; 40:1109–20.